SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes

被引:0
|
作者
Irwin Jungreis
Rachel Sealfon
Manolis Kellis
机构
[1] MIT Computer Science and Artificial Intelligence Laboratory,Center for Computational Biology
[2] Broad Institute of MIT and Harvard,undefined
[3] Flatiron Institute,undefined
[4] Simons Foundation,undefined
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Despite its clinical importance, the SARS-CoV-2 gene set remains unresolved, hindering dissection of COVID-19 biology. We use comparative genomics to provide a high-confidence protein-coding gene set, characterize evolutionary constraint, and prioritize functional mutations. We select 44 Sarbecovirus genomes at ideally-suited evolutionary distances, and quantify protein-coding evolutionary signatures and overlapping constraint. We find strong protein-coding signatures for ORFs 3a, 6, 7a, 7b, 8, 9b, and a novel alternate-frame gene, ORF3c, whereas ORFs 2b, 3d/3d-2, 3b, 9c, and 10 lack protein-coding signatures or convincing experimental evidence of protein-coding function. Furthermore, we show no other conserved protein-coding genes remain to be discovered. Mutation analysis suggests ORF8 contributes to within-individual fitness but not person-to-person transmission. Cross-strain and within-strain evolutionary pressures agree, except for fewer-than-expected within-strain mutations in nsp3 and S1, and more-than-expected in nucleocapsid, which shows a cluster of mutations in a predicted B-cell epitope, suggesting immune-avoidance selection. Evolutionary histories of residues disrupted by spike-protein substitutions D614G, N501Y, E484K, and K417N/T provide clues about their biology, and we catalog likely-functional co-inherited mutations. Previously reported RNA-modification sites show no enrichment for conservation. Here we report a high-confidence gene set and evolutionary-history annotations providing valuable resources and insights on SARS-CoV-2 biology, mutations, and evolution.
引用
收藏
相关论文
共 50 条
  • [41] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [42] SARS-CoV-2 Targets and COVID-19 Vaccines
    Currier, Arthur W.
    Jeshurin, Madeline C.
    Sampson, Valerie B.
    COVID, 2021, 1 (03): : 608 - 621
  • [43] SARS-CoV-2/COVID-19: a primer for cardiologists
    de Vries, A. A. F.
    NETHERLANDS HEART JOURNAL, 2020, 28 (7-8) : 366 - 383
  • [44] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Piasecki, Egbert
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (06)
  • [45] SARS-CoV-2 Infection and COVID-19 in Children
    Waghmare, Alpana
    Hijano, Diego R.
    CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
  • [46] Adaptive immunity to SARS-CoV-2 and COVID-19
    Sette, Alessandro
    Crotty, Shane
    CELL, 2021, 184 (04) : 861 - 880
  • [47] SARS-CoV-2: Remarks on the COVID-19 Pandemic
    Egbert Piasecki
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [48] Decoding Covid-19 with the SARS-CoV-2 Genome
    Ellis, Phoebe
    Somogyvari, Ferenc
    Virok, Dezso P.
    Noseda, Michela
    McLean, Gary R.
    CURRENT GENETIC MEDICINE REPORTS, 2021, 9 (01) : 1 - 12
  • [49] Infection with SARS-CoV-2 is not the same as covid-19
    Bamji, Andrew
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [50] Retracted papers on SARS-CoV-2 and COVID-19
    Cortegiani, Andrea
    Catalisano, Giulia
    Ippolito, Mariachiara
    Giarratano, Antonino
    Absalom, Anthony R.
    Einav, Sharon
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (04) : E155 - E156